ARTICLE | Company News
DiagnoCure, Signal Genetics deal
March 18, 2013 7:00 AM UTC
In January, DiagnoCure and partner Signal Genetics terminated a June 2011 deal granting Signal Genetics exclusive, worldwide rights to Previstage GCC Colorectal Cancer Staging Test. DiagnoCure, which...